Phenotypic Expression of Hypersensitivity Drug Reactions in Outpatient Infusion Centers, 1 Year Experience

Methods A retrospective review was performed of patient reactions that included iron products, monoclonal antibodies, and chemotherapeutic agents at three Dana-Farber Satellite Clinics (DFSC) from March 2016-April 2017. Type I (IgE medicated, involving mast cells), Cytokine-Release Reaction (CRR), M...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB78-AB78
Main Authors: Falck-Fuentes, Cintia A., Jimenez Rodriguez, Teodorikez W., Lynch, Donna-Marie, Garcia-Neuer, Marlene, Marquis, Kathleen A., Alenazy, Leila A., Castells, Mariana C.
Format: Article
Language:English
Subjects:
Hypersensitivity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods A retrospective review was performed of patient reactions that included iron products, monoclonal antibodies, and chemotherapeutic agents at three Dana-Farber Satellite Clinics (DFSC) from March 2016-April 2017. Type I (IgE medicated, involving mast cells), Cytokine-Release Reaction (CRR), Mixed reactions (clinical symptoms including Type 1 an CRR); as well as, grade of reaction, and outcomes was collected.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2017.12.252